Abstract:The search for new cytotoxic agents capable of lysing tumor cells is an important task in the fight against cancer. Here we have shown that the HspBP1 protein, the chaperone of the heat shock protein Hsp70, is able to form a complex with the previously discovered peptide (17.1) of the innate immunity protein Tag7. Experiments using thermophoresis demonstrated that the affinity of the Tag7 protein peptide 17.1 to the HspBP1 molecule is 100 times higher than that of the full-sized Tag7 molecule. The addition of the 17.1–HspBP1 complex to tumor cells induces apoptosis and necroptosis in them. The results obtained in this work can be used to develop promising antitumor drugs.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to find new cytotoxic agents capable of lysing tumor cells in order to fight against cancer. Specifically, the study focused on whether the complex formed by the chaperone protein HspBP1 of heat shock protein 70 (Hsp70) and the peptide fragment (17.1 peptide) of the innate immune protein Tag7 can induce apoptosis and necroptosis in tumor cells. By comparing the characteristics of the complexes formed by Tag7 protein and its functional peptide fragment 17.1 with HspBP1 protein and studying the cytotoxic activities of these complexes, the study aims to develop new anti - tumor drugs. The key points of the paper include: 1. **Background**: Tumor necrosis factor (TNF) is one of the earliest described cytotoxic proteins. It induces intracellular signal transduction by interacting with cell - surface receptors, which in turn leads to apoptosis or necroptosis. TNFR1 is the most important TNF - specific receptor and is widely present in various tissues and cells, including tumor cells. 2. **Objective**: To study the ability of HspBP1 to form a complex with the peptide fragment 17.1 of Tag7 and its cytotoxic activity. 3. **Methods**: - Use thermophoresis to evaluate the binding affinity of Tag7 protein and its peptide fragment 17.1 with HspBP1. - Evaluate the cytotoxicity of different complexes on L929 cells (mouse fibroblasts) through cell experiments. 4. **Results**: - The binding affinity of HspBP1 with the 17.1 peptide is 100 times higher than that with the intact Tag7 protein. - The 1:2 complex formed by the 17.1 peptide and HspBP1 shows cytotoxicity after incubation for 3 hours and 20 hours, and this cytotoxicity can be inhibited by adding anti - TNFR1 antibody. 5. **Conclusion**: The complex formed by the 17.1 peptide and HspBP1 can induce apoptosis and necroptosis in tumor cells by interacting with the TNFR1 receptor, which provides a potential approach for the development of new anti - tumor drugs. Through these studies, the paper provides an important scientific basis for understanding the mechanism of tumor cell death and developing new anti - tumor immunotherapies.

HspBP1 in Complex with the Peptide of the Innate Immunity Protein Tag7 is Able to Lyse Tumor Cells Carrying TNFR1 Receptor

Mts1 (S100A4) and Its Peptide Demonstrate Cytotoxic Activity in Complex with Tag7 (PGLYRP1) Peptide

Message in a bottle: role of the 70-kDa heat shock protein family in anti-tumor immunity

A 14-mer Peptide from HSP70 Protein is the Critical Epitope Which Enhances NK Activity Against Tumor Cells in vivo

The 12-Membered TNFR1 Peptide, as Well as the 16-Membered and 6-Membered TNF Peptides, Regulate TNFR1-Dependent Cytotoxic Activity of TNF

Withdrawal: A Novel Human Phosphatidylethanolamine-Binding Protein Resists Tumor Necrosis Factor Α-Induced Apoptosis by Inhibiting Mitogen-Activated Protein Kinase Pathway Activation and Phosphatidylethanolamine Externalization.

A Modified HLA-A*0201-restricted CTL Epitope from Human Oncoprotein (hpebp4) Induces More Efficient Antitumor Responses

Targeted Delivery of HSP70 to Tumor Cells via Supramolecular Complex Based on HER2-Specific DARPin9_29 and the Barnase:Barstar Pair

Crosstalk Between NK Cell Receptors and Tumor Membrane Hsp70‐Derived Peptide: A Combined Computational and Experimental Study

Major heat shock protein hsp70 protects tumor cells from tumor necrosis factor cytotoxicity.

The TAT-RasGAP317-326 anti-cancer peptide can kill in a caspase-, apoptosis-, and necroptosis-independent manner

Identification of a protein with homology to hsp90 that binds the type 1 tumor necrosis factor receptor

TAT-RasGAP317-326 kills cells by targeting inner-leaflet-enriched phospholipids

70 kDa heat shock cognate protein is a transformation-associated antigen and a possible target for the host's anti-tumor immunity.

Binding of Peptides Containing D‐Amino Acids to the Tsg101 Tumor Susceptibility Protein

Hsp70-Bim interaction facilitates mitophagy by recruiting parkin and TOMM20 into a complex

Tat-hspb1 Suppresses Clear Cell Renal Cell Carcinoma (ccrcc) Growth Via Lysosomal Membrane Permeabilization

DTX-P7, a peptide–drug conjugate, is highly effective for non-small cell lung cancer

Targeted delivery of chemotherapy using HSP90 inhibitor drug conjugates is highly active against pancreatic cancer models

The Efficiency of Tumor-Specific Ph-Responsive Peptide-Modified Polymeric Micelles Containing Paclitaxel.

A functional recombinant single-chain T cell receptor fragment capable of selectively targeting antigen-presenting cells